Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-25

FDA Approved: ZYPITAMAG — Supplemental Application (Medicure International Inc)

View source ↗

Summary

The FDA has approved a supplemental application for ZYPITAMAG (pitavastatin magnesium) filed by Medicure International Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYPITAMAG (PITAVASTATIN MAGNESIUM)

Snippet

SUPPL AP for ZYPITAMAG (PITAVASTATIN MAGNESIUM)